Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 72789-084

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 72789-084). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789084 Label (72789084)

Label for Atorvastatin Calcium USP 20 mg tablets, film-coated, 30 count, from PD-Rx Pharmaceuticals, Inc. The label includes the NDC number 72789-084-30 and features a green and white color scheme with a prominent PD-Rx logo. Additional data such as lot number E20C29 and expiration date 04/2021 are shown, along with a barcode and ordering information.*

FDA Label Image

Figure-01 (Atorvastatin Figure 01)

A line graph showing cumulative incidence (%) over a 3.5 year period comparing Atorvastatin and Placebo groups. The solid line represents Atorvastatin, with lower cumulative incidence than the dashed Placebo line. The hazard ratio (HR) is 0.64 with a 95% confidence interval of 0.50 to 0.83, and the p-value is 0.0005, indicating statistical data related to Atorvastatin's effects over time.*

FDA Label Image

Figure-02 (Atorvastatin Figure 02)

A line graph comparing the cumulative hazard percentage over up to 5 years of follow-up between Atorvastatin and placebo groups. The x-axis shows time to first primary endpoint in years, and the y-axis shows cumulative hazard percentage. Atorvastatin is represented by a solid line, placebo by a dashed line, with Atorvastatin showing a lower cumulative hazard over time compared to placebo.*

FDA Label Image

Figure-03 (Atorvastatin Figure 03)

A line graph showing the percentage of subjects experiencing the first major cardiovascular event over time in years for Atorvastatin 10 mg and 80 mg doses. The x-axis represents time to first major cardiovascular endpoint (0 to 5 years), and the y-axis the percentage of subjects experiencing the event (0 to 0.2%). Two lines compare 10 mg (dashed) and 80 mg (solid) doses, with a hazard ratio (HR 0.78) and p-value (0.0002) indicated.*

FDA Label Image

Structure (Atorvastatin Structure)

Chemical structure diagram depicting the molecular composition of atorvastatin calcium, showing its core components including rings, bonds, calcium ion, and associated water molecules (hydration).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.